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Objectives: To enhance the quality of diabetes care in
the Netherlands, so-called care groups with three to 250
general practitioners emerged to organise and
coordinate diabetes care. This introduced a new quality
management level in addition to the quality management
of separate general practices. We hypothesised that this
new level of quality management might be associated
with the aggregate performance indicators on the patient
level. Therefore, we aimed to explore the association
between quality management at the care group level and
its aggregate performance indicators.
Design: A cross-sectional study.
Setting: All Dutch care groups (n=97).
Participants: 23 care groups provided aggregate
register-based performance indicators of all their
practices as well as data on quality management
measured with a questionnaire filled out by 1 or 2 of
their quality managers.
Primary outcomes: The association between quality
management, overall and in 6 domains (‘organisation of
care’, ‘multidisciplinary teamwork’, ‘patient centredness’,
‘performance management’, ‘quality improvement policy’
and ‘management strategies’) on the one hand and 3
process indicators (the percentages of patients with at
least 1 measurement of glycated haemoglobin, lipid
profile and systolic blood pressure), and 3 intermediate
outcome indicators (the percentages of patients with
glycated haemoglobin below 53 mmol/mol (7%); low-
density lipoprotein cholesterol below 2.5 mmol/L; and
systolic blood pressure below 140 mm Hg) by weighted
univariable linear regression.
Results: The domain ‘management strategies’ was
significantly associated with the percentage of patients
with a glycated haemoglobin <53 mmol/mol (β 0.28
(0.09; 0.46) p=0.01) after correction for multiple
testing. The other domains as well as overall quality
management were not associated with aggregate
process or outcome indicators.
Conclusions: This first exploratory study on quality
management showed weak or no associations between
quality management of diabetes care groups and their
performance. It remains uncertain whether this second
layer on quality management adds to better quality of
care.
INTRODUCTION
The delivery of optimal diabetes care is becom-
ing increasingly complex.1 Fast-growing
medical knowledge and increasing attention
to quality of care has changed patient care
into multiprofessional teamwork involving
many healthcare providers.2 Consequently,
optimal collaboration and coordination
among these professionals and the patient has
become essential for delivering high quality of
care.1 To enhance the quality of care in the
Netherlands, so-called care groups emerged to
organise and coordinate multidisciplinary dia-
betes care.3 They are similar to Accountable
Care Organizations in the USA3 4 and Clinical
Commission Groups in the UK.5
In the Netherlands, with a diabetes preva-
lence of 5%, about 85% of people with type
2 diabetes are treated by general practi-
tioners and practice nurses in general prac-
tices, almost all within the frame of a care
group.6 In 2012, there were about 100 dia-
betes care groups, with anywhere from 3 to
Strengths and limitations of this study
▪ For the first time, quality management and per-
formance indicators at an aggregate level were
measured at about the same time, and put
together.
▪ Data represent 24% of all Dutch care groups,
spread over the country, and accountable for the
treatment of 189 000 diabetes patients.
▪ Selection bias could not be ruled out as partici-
pating care groups with better quality manage-
ment seemed more willing to participate in both
studies.
▪ The cross-sectional design does not allow the
drawing of causal relationships.
▪ For further research, confirmatory factor analyses
of the questionnaire should be performed and
criterion validity should be tested if comparable
instruments become available.
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250 general practitioners involved in each; the care
groups treat between 400 and 22 500 diabetes patients.7
These care groups are the main contractor of a diabetes
care programme, and are responsible for the organisa-
tion, coordination and delivery of diabetes care. Their
diabetes care programme is based on the Dutch
Diabetes Federation healthcare standard for type 2 dia-
betes, which describes good quality diabetes care and
corresponding performance indicators.8 To get the
quality of their contracted diabetes care checked, care
groups are obliged by health insurance companies
(that pay for the diabetes care) to provide aggregate
performance indicators on an annual basis. Based on
recent data from 48 care groups, glycated haemoglobin
(HbA1c) <53 mmol/mol (7%) has been achieved in
two of three patients, 52% of the patients have systolic
blood pressure (SBP) <140 mm Hg and 53% of the
type 2 diabetes patients have low-density lipoprotein
(LDL) cholesterol <2.5 mmol/L.9 Care groups are con-
tinuously working on improving the registration of
these indicators.9
Quality of care is at least partially the outcome of a
controlled process: quality management. Quality man-
agement comprises of procedures to monitor, assess and
improve the quality of care.10 Individual general prac-
tices have different levels of quality management. The
introduction of care groups created a second level of
quality management, in addition to the level of general
practice. The level of quality management in care
groups varies, for example, in the way they organise post-
graduate courses, support self-management or handle
electronic patient records and benchmarks.11 Using a
benchmark, a care group can address poorly performing
general practices. We could demonstrate that the level of
quality management in care groups may be improved by
providing feedback and a benchmark.12 In our opinion,
focusing on quality management is only justified if
better quality management leads to better patient out-
comes. A meta-analysis of quality improvement strategies
showed that interventions across the entire system of
chronic disease management, such as team changes,
case management, promotion of self-management, edu-
cation of patients as well as clinicians, and electronic
patient registry diabetes management, were associated
with improvements on HbA1c, LDL cholesterol, and sys-
tolic and diastolic blood pressure in diabetes care.13
However, the studies in this review were targeted at prac-
tice level. On the other hand, a systematic review found
that the structure of diabetes care, for example, the
adequacy of facilities, equipment, logistics, or registra-
tion, were not related to (surrogate) patient outcomes.14
Hence, it remains unclear whether a good quality man-
agement system on care group level in addition to the
quality management in individual general practices
might result in better process and outcome measures for
patients. Therefore, we aim to explore the association
between quality management at the care group level
and aggregate performance indicators of care groups.
METHODS
Study population and design
This cross-sectional study is based on data of 23 care
groups participating in two studies (figure 1):
1. Study I: measuring quality management at care
group level (60 care groups) (see Level of quality
management section)11 15
2. Study II: measuring aggregated performance indica-
tors of care groups (66 care groups) (see Diabetes
performance indicators section).9
Forty-six of the 66 care groups participating in study II
gave consent for linking their scores on the perform-
ance indicators to their scores on quality management.
However, only 23 of these care groups also participated
in study I. The number of care groups participating in
the current study represents 24% of all Dutch care
groups, spread all over the country and accountable for
the treatment of 189 000 diabetes patients.
No ethical approval was needed.
Measurements
Level of quality management
Between January and March 2012, those responsible for
diabetes quality management of all care groups (n=97)
were invited to fill out an online questionnaire measur-
ing quality management in their care group (study I).
Quality management was assessed in six domains:
‘organisation of care’, ‘multidisciplinary teamwork’,
‘patient centredness’, ‘performance management’,
‘quality improvement policy’ and ‘management strat-
egies’ (score range 0–100%). Details of the question-
naire have been described elsewhere.11 15 The mean
score of these six domains is the total level of quality
management.11 15 Within the domains, 27 subdomains
were addressed, each subdomain containing 1–6 ques-
tions. Each question was given equal weight; all ques-
tions within a subdomain contributed X% to the score
of a domain, where X was the mean weight per subdo-
main given by an expert panel. The score of a subdo-
main could vary between 0% and 100%.
The whole questionnaire contained 59 questions; each
question had a maximum score of 1 point.16 Since there
were different types of questions, different types of
scoring were used. Some questions had X subquestions;
each subquestion could count for a maximum score of
1/X. The score was higher when the developmental stage
on an item, for instance, benchmarking, was higher. For
example, on the question “Is benchmarking being used
in your care group to make improvements?”, organisa-
tions scored 0 point if they had no policy on benchmark-
ing. If benchmarking was occasionally used, the score was
0.33 points; if the policy to structurally use benchmarking
for quality improvement was still under development,
they scored 0.66 points; and if benchmarking was struc-
turally used for quality improvement, the score was 1
point. In questions in which we assessed the number of
care providers involved in a particular item, each involved
care provider scored 1/Y to the maximum score of 1
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point. In the latter type of question, for example, a ques-
tion such as “For which care providers has the care group
organised postgraduate education in the past year?”, the
maximum score could be reached when a defined
number (Y) of care providers was involved. A copy of the
questionnaire and the scoring of the questionnaire is
included (see supplementary additional file).
The questionnaire’s construct validity was based on
the literature and a review of seven models for quality
management, resulting in the six domains for diabetes
quality management.17 Its face and content validity were
warranted by involving experts in a pilot study, and by
the weighing of the subdomains within a domain by an
expert panel.11 15 Furthermore, the Cohen’s κ of the
questionnaires, which was tested by allowing two respon-
dents of the same organisation to fill out the same ques-
tionnaire independently,16 seemed to be acceptable.
Criterion-related validity could not be tested since there
were no comparable instruments available.
Diabetes performance indicators
The Integrated Care Organisation, a national advisory
group to support care groups, collected results on
performance indicators concerning the year 2011 from
care groups (Study II).9 These indicators were based on
the Dutch diabetes care standard,8 and consisted of
process as well as outcome indicators.
Process indicators show whether tests or assessments
have been completed, such as the percentage of patients
whose level of HbA1c has been measured in the preced-
ing 12 months. The nominator per care group is the
number of patients with a measurement in 2011; the
denominator is the total number of patients participat-
ing in a particular care group.
Outcome indicators reflect the results of an assess-
ment. The nominator is the number of patients with a
measurement and achieving a specific target (such as
the number of patients with an HbA1c below 53 mmol/
mol (7%)); the denominator is the total number of
patients with such a measurement in a particular care
group. The process and indicators used by the
Integrated Care Organisation are shown in table 1.
We used three process indicators, the percentages of
patients with at least one recording of HbA1c, lipid
profile and blood pressure, in 2011. Besides, we used
three outcome indicators, the percentages of patients
Figure 1 Flowchart inclusion care groups.
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with: HbA1c <53 mmol/mol (7%); LDL cholesterol <2.5
mmol/L; and SBP <140 mm Hg.
Indicators not used in the analyses were performance
indicators on smoking status, because of inappropriate
registration mainly in non-smokers; indicators on eye
and foot examination, because there was no information
of patients treated by ophthalmologists and chiropodists,
respectively; the measurements on kidney function
because of different registration methods; and the per-
centage of people using lipid lowering drugs and both
indicators with regard to body mass index because of
incomplete registration. Owing to the problems with
these indicators we also decided not to use the overall
indicator.
Next to the individual care group information on per-
formance indicators of the 23 care groups participating
in both study I and II, we also received the total mean
(SD) on the performance indicators of all care groups
in study II (N=66) together.
Statistical analysis
Descriptive data analyses were used for the baseline
results. One-way analysis of variance (ANOVA) was used
to check the difference on total quality management
score between the 23 participating care groups in this
study and the 37 non-participating care groups from
study II (figure 1). Further, we compared the difference
on performance indicators between the 23 participating
organisations and the total group of all participants
from study II (N=66).
To explore the association between quality manage-
ment level and performance indicators, first, the associa-
tions between the quality management domain scores
were analysed. If the quality domains were associated
with each other a multiple regression analysis would be
preferred. Weighted univariable linear regression ana-
lyses were performed between, on the one hand, the
total level of quality management of a care group and
all six quality management domains, separately; and the
aforementioned process and outcome indicators on the
other. These linear regressions were weighted for the
square root of the number of patients with diabetes
treated in a care group.
Further, we checked whether care group size con-
founded these associations, by checking associations
between care group size and the quality domains, or
between care group size and the process and outcome
indicators. Since each weighted linear regression was
performed with seven separate variables, we considered
a p value of 0.01 significant in this explorative study. For
all other tests, a p value of 0.05 was considered signifi-
cant. The assumptions for linear regression were
checked. Analyses were performed using the SPSS 20.0
statistic software package.
RESULTS
Table 2 shows the baseline characteristics of the partici-
pating care groups (N=23). Their mean overall level of
quality management was 63.9% (CI 60.5% to 67.2%);
the highest score regarded the domain of ‘organisation
Table 1 Overview of the process and outcome measures in diabetes care groups
Parameter Process measure Outcome measure
HbA1c Percentage of patients with HbA1c measured in 2011 Percentage of patients with HbA1c<53 mmol/
mol (7%)
Percentage of patients with HbA1c>69 mmol/
mol (8.5%)
Cholesterol Percentage of patients with lipid profile measured
in 2011
Percentage of patients with LDL<2.5 mmol/L
Lipid-lowering
drugs
Percentage of patients using lipid lowering
drugs
Renal function Percentage of patients with at least one creatinine
measurement in 2011
Percentage of patients with at least one urine albumin
measurement in 2011
Blood pressure Percentage of patients with at least one blood pressure
measurement in 2011
Percentage of patients with SBP<140 mm Hg
BMI Percentage of patients with BMI measured in 2011 Percentage of patients with BMI<25 (kg/m2)
Smoking status Percentage of patients with their smoking behaviour
recorded in 2011
Percentage of patients that smoked
Percentage of patients that received smoking
cessation advice
Eye examination Percentage of patients with their eyes examined in 2011 Percentage of patients with retinopathy
Foot examination Percentage of patients with their feet examined in 2011
Overall indicator Percentage of patients fulfilling all aforementioned
measurements
Text in italic represents measures used in this study.
BMI, body mass index; HbA1c, glycated haemoglobin; LDL, low-density lipoprotein; SBP, systolic blood pressure.
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of care’ (72.6%, CI 68% to 77.1%). For the performance
indicators, 92.3% (CI 89.8% to 94.8%) of the patients
had at least one yearly recording of blood pressure and
two of three had an HbA1c <53 mmol/mol (67.7%, CI
65.5% to 69.8%).
The 23 participating care groups had significantly
better total quality management than the 37 care
groups of which no data on performance indicators
were available (57%; CI 53.7% to 60.2%; p=0.01). In
study II, the mean percentage of patients from 66 care
groups with at least one annual measurement of HbA1c
was 91.7% (SD 6.7%) and the percentage of patients
with an HbA1c <53 was 68.5% (SD 7.6%),9 whereas the
23 participating care groups in our study scored 92.3%
(CI 89.8% to 94.8%) and 67.7% (CI 65.5% to 69.8%),
respectively (table 2).
Since there were some significant univariable associa-
tions between the quality management domain scores, a
multivariable linear regression would have been prefer-
able but there were too few participating care groups to
do so. In the univariable analysis, there were no signifi-
cant associations between the level of quality manage-
ment of care groups, and both its aggregate process and
outcome indicators, with the exception of an association
between the domain ‘management strategies’ and the
number of patients achieving an HbA1c <53 mmol/mol
(β 0.28 (0.09 to 0.46) p=0.01) (table 3). Care group
size was associated with neither the total quality
management score (r=−0.07; p=0.76) nor with the
domains.
Table 2 Baseline characteristics of the care groups
(N=23) (percentages)
Baseline characteristics Mean (CI)
Number of patients in diabetes
care programme
8586 (6025 to 11 148)
Overall level of QM 63.9 (60.5 to 67.2)
QM score in ‘organisation of care’ 72.6 (68.0 to 77.1)
QM score in ‘multidisciplinary
teamwork’
68.6 (61.3 to 76.0)
QM score in ‘patient centredness’ 50.4 (43.5 to 57.4)
QM score in ‘performance
management’
67.0 (63.8 to 70.3)
QM score in ‘quality improvement
strategy’
59.1 (54.7 to 63.4)
QM score in ‘management
strategies’
65.4 (60.4 to 70.5)
Patients with at least one
measurement of HbA1c in 2011
91.0 (88.2 to 93.8)
Patients with at least one
recording of lipid profile in 2011
86.4 (83.0 to 90.0)
Patients with at least one
recording of blood pressure in
2011
92.3 (89.8 to 94.8)
Patients with HbA1c <53 mmol/mol 67.7 (65.5 to 69.8)
Patients with LDL cholesterol
<2.5 mmol/L*
53.9 (51.5 to 56.3)
Patients with SBP <140 mm Hg 54.2 (52.5 to 55.9)
*In one care group there was no good extraction of LDL
measurements.
HbA1c, glycated haemoglobin; LDL, low-density lipoprotein;
QM, quality management; SBP, systolic blood pressure.
Table 3 Weighted univariable linear regression between overall quality management, quality management in the domains
and performance indicators
Quality management
Process indicators (percentage of patients measured in 2011)
HbA1c LDL cholesterol Blood pressure
Organisation of care 0.01 (−0.25 to 0.27) 0.94 0.13 (−0.19 to 0.46) 0.41 0.11 (−0.14 to 0.36) 0.38
Multidisciplinary teamwork −0.10 (−0.26 to 0.07) 0.24 −0.12 (−0.32 to 0.09) 0.26 −0.12 (−0.28 to 0.04) 0.12
Patient centredness −0.003 (−0.18 to 0.17) 0.97 0.03 (−0.19 to 0.25) 0.76 −0.01 (−0.18 to 0.17) 0.94
Performance management 0.13 (−0.32 to 0.57) 0.56 0.17 (−0.39 to 0.73) 0.54 0.15 (−0.29 to 0.58) 0.49
Quality improvement strategies −0.04 (−0.37 to 0.28) 0.78 −0.09 (−0.50 to 0.33) 0.67 −0.03 (−0.36 to 0.29) 0.84
Management strategies 0.24 (−0.03 to 0.51) 0.08 0.25 (−0.10 to 0.60) 0.16 0.18 (−0.09 to 0.46) 0.18
Total mean −0.01 (−0.40 to 0.39) 0.97 0.05 (−0.45 to 0.55) 0.84 −0.01 (−0.39 to 0.38) 0.97
Outcome indicators (percentage of patients below target)
HbA1c <53 mmol/mol (7%) LDL cholesterol*< 2.5 mmol/L SBP <140 mm Hg
Organisation of care 0.05 (−0.15 to 0.26) 0.58 0.02 (−0.17 to 0.22) 0.80 −0.02 (−0.17 to 0.13) 0.80
Multidisciplinary teamwork 0.01 (−0.12 to 0.14) 0.82 0.04 (−0.10 to 0.18) 0.53 −0.01 (−0.10 to 0.09) 0.89
Patient centredness 0.06 (−0.08 to 0.19) 0.39 0.08 (−0.05 to 0.21) 0.21 0.05 (−0.04 to 0.15) 0.28
Performance management −0.01 (−0.35 to 0.34) 0.97 −0.08 (−0.42 to 0.25) 0.60 −0.04 (−0.30 to 0.21) 0.74
Quality improvement strategies −0.04 (−0.30 to 0.21) 0.72 0.10 (−0.15 to 0.35) 0.41 −0.004 (−0.19 to 0.18) 0.97
Management strategies 0.28 (0.09 to 0.46) 0.01 −0.004 (−0.23 to 0.22) 0.97 −0.05 (−0.22 to 0.11) 0.52
Total mean 0.15 (−0.14 to 0.45) 0.29 0.12 (−0.18 to 0.42) 0.40 0.01 (−0.22 to 0.23) 0.93
The numbers in each cell represent, respectively, the β, (95% CI) and p value. β is the expected change in the performance indicators for
1-unit change in quality management. If, for example, the score on management strategies changes 1%, then the number of patients with an
HbA1c<53 mmol/mol is expected to rise with 0.28% (CI 0.09 to 0.46) %.
*In one care group there was no good extraction of LDL measurements.
Bold typeface indicates significance at p<0.01.
HbA1c, glycated haemoglobin; LDL, low-density lipoprotein; SBP, systolic blood pressure.
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This is an explorative study on the association between
quality management of care groups, in addition to the
existing quality management in separate general prac-
tices, and their aggregate performance indicators. It
showed a significant association between the manage-
ment strategies of a care group and the percentage of
patients with an HbA1c <53 mmol/mol. Other associa-
tions between quality management and performance
indicators did not reach significance.
Management strategies comprised of three subdo-
mains: (1) a structural policy (with questions on the
use of the Plan-Do-Check-Act cycle), (2) the availability
of quality systems (questioning whether a certified
quality system was used on care group or practice
level) and (3) the availability of quality documents
(such as a mission document, a quality action plan or
an annual quality report). The combination of these
factors could create preconditions for better blood
glucose control in the practices belonging to a care
group. But care should be taken when drawing conclu-
sions from the associations we found in this domain. It
remains unclear why no associations between other
quality management domains and lipid or blood pres-
sure management were shown. However, a previous
review found no association between adequacy of facil-
ities, equipment, logistics, or registration and (surro-
gate) patient outcomes, either.14
There are several reasons that might explain the lack of
significant associations between quality management and
performance indicators on the level of care groups. First,
we measured quality management with an instrument
that was not yet completely validated, although it was
developed carefully and we demonstrated its ability to
measure change in quality management over a 1-year
period.12 Second, individual general practices might
already have such good quality management that the
‘second level’ of quality management of the care groups
does not further improve their diabetes care. We had no
information on the differences between individual
general practices; neither on their quality management
levels nor on the variance of their scores on performance
indicators. Assuming that an active quality management
policy at the care group level will focus on practices that
perform less well, it is plausible that a higher level of
quality management on care group level would result in
less variance between practices and less ‘bad’ practices.
However, to support this hypothesis, data from separate
practices should be available, beyond the aggregate data
we used in this study. If, in future study, these data on
practice level become available, then a multilevel analysis
would be appropriate with these multilevel data. Third,
quality improvements are likely to be more effective if
baseline levels of intermediate outcomes are poor. In the
Netherlands, the results of diabetes care are good com-
pared with those of other European countries.18 Close
collaboration between general practitioners and practice
nurses already led to significant improvements in
diabetes care.19 Fourth, we measured a limited set of per-
formance indicators, because of problems with the regis-
tration of other ones. The number of adequately
registered performance indicators depends on both the
registration by the healthcare providers, and on the per-
formance of the software companies that provide the
registration software and the aggregate data reports.7
Dutch diabetes care groups, which are obliged to provide
annual benchmark reports, put much effort into optimis-
ing the data exchange between the practices and the care
groups, but still experience difficulties.20 Owing to tech-
nical problems, performance indicators are often regis-
tered and/or extracted inappropriately.9 We cannot rule
out the possibility of analysis of a larger set of indicators
demonstrating significant associations with the quality
management of care groups. Besides, patient satisfaction
and patient safety, which are no part of the national
benchmark, were not measured. The domain ‘patient
centredness’ might be more likely associated with patient-
reported outcome measures. Fifth, the number of partici-
pating care groups might have been too low to achieve
significant results. Finally, we should not exclude the pos-
sibility that there is indeed no relationship between the
level of quality management at care group level and
aggregate performance indicators.
Our study could enhance the improvement of quality
management. Participating organisations already used
the questionnaire as a checklist to ascertain whether
several quality management items were present. However,
if, indeed, there would be no association between quality
management in care groups and their performance out-
comes, the Health Inspectorate and health insurance
companies should not focus on the level of quality man-
agement in care groups. However, we cannot yet draw
this conclusion. First, the quality management instru-
ment needs further validation. Second, the variation in
performance indicators between practices needs to be
studied. Third, the registration of performance indicators
still needs improvement, although the extraction of per-
formance indicators becomes increasingly more reliable.
Besides, differences in population (case-mix) will influ-
ence the performance indicators as well and, in present-
ing indicators, adjustment for case-mix is obligatory.21
Although one should realise that improved recording is
not necessarily a valid indicator of good quality of care,22
the only way we can measure quality of care with perform-
ance indicators is basing it on registration data. Finally, to
establish a good quality management system may take
several years.
A strength of this study is that, for the first time,
quality management and performance indicators at an
aggregate level were measured and put together at
about the same time. This gave us the unique opportun-
ity to study the association between the quality manage-
ment at care group level, above what happens at the
general practice level, and performance indicators.
A limitation of this study is the availability of both data-
sets of only 23 care groups. Although we may assume
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that the care groups participating in this study were com-
parable with all 66 care groups in study II, with regard
to their performance indicators, selection bias cannot
be ruled out, as participating care groups with better
quality management seemed more willing to participate,
in both studies. Further limitations are the cross-
sectional design and the validity of the questionnaire. A
cross-sectional design is not suitable to detect a causal
relationship between quality of diabetes management
and quality indicators. Face and content validity were
warranted, and construct validity was based on the litera-
ture and a review of seven quality management models.
As stated above, we demonstrated its ability to measure
change in quality management over a 1-year period.12
However, if the questionnaire were to be used for
further research, confirmatory factor analyses should be
performed and criterion validity tested if comparable
instruments become available.
To conclude: we could not demonstrate an association
between quality management of care groups and better
outcomes in diabetes care.
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